BioMarin Pharmaceutical Inc.BMRNNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -872.52% |
| Q3 2025 | -116.86% |
| Q2 2025 | 23.67% |
| Q1 2025 | 38.71% |
| Q4 2024 | 41.72% |
| Q3 2024 | -5.45% |
| Q2 2024 | 36.16% |
| Q1 2024 | 522.14% |
| Q4 2023 | -53.42% |
| Q3 2023 | -53.44% |
| Q2 2023 | 5.07% |
| Q1 2023 | 354.71% |
| Q4 2022 | -913.65% |
| Q3 2022 | -106.17% |
| Q2 2022 | -71.49% |
| Q1 2022 | 308.45% |
| Q4 2021 | -23.79% |
| Q3 2021 | -555.95% |
| Q2 2021 | -53.47% |
| Q1 2021 | 155.95% |
| Q4 2020 | 19.84% |
| Q3 2020 | -36.62% |
| Q2 2020 | -139.01% |
| Q1 2020 | 1245.61% |
| Q4 2019 | -328.48% |
| Q3 2019 | 109.70% |
| Q2 2019 | 23.35% |
| Q1 2019 | -41.43% |
| Q4 2018 | -142.35% |
| Q3 2018 | 37.69% |
| Q2 2018 | 43.07% |
| Q1 2018 | -176.44% |
| Q4 2017 | 522.87% |
| Q3 2017 | 64.63% |
| Q2 2017 | -92.06% |
| Q1 2017 | 77.45% |
| Q4 2016 | -49.16% |
| Q3 2016 | 89.51% |
| Q2 2016 | -607.89% |
| Q1 2016 | -179.86% |